Canlyniadau Chwilio - David Cuthbertson

Mireinio'r Canlyniadau
  1. 1
    Prevalence and Significance of Retinopathy in Subjects With Type 1 Diabetes of Less Than 5 Years’ Duration Screened for the Diabetes Control and Complications Trial

    Prevalence and Significance of Retinopathy in Subjects With Type 1 Diabetes of Less Than 5 Years’ Duration Screened for the Diabetes Control and Complications Trial gan John I. Malone, Anthony Morrison, Peter R. Pavan, David Cuthbertson

    Cyhoeddwyd 2001
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Long-Term Outcome of Individuals Treated With Oral Insulin

    Long-Term Outcome of Individuals Treated With Oral Insulin gan Kendra Vehik, David Cuthbertson, Holly Ruhlig, Desmond Schatz, Mark Peakman, Jeffrey P. Krischer

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Role of Insulin Resistance in Predicting Progression to Type 1 Diabetes

    Role of Insulin Resistance in Predicting Progression to Type 1 Diabetes gan Ping Xu, David Cuthbertson, Carla J. Greenbaum, Jerry P. Palmer, Jeffrey P. Krischer

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review

    Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review gan Mousumi Bose, Christine Yergeau, Yasmin D’Souza, David Cuthbertson, Melisa J. Lopez, Alyssa Smolen, Nancy Braverman

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives

    HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives gan Alessandra Petrelli, Federica Cugnata, Debora Carnovale, Emanuele Bosi, Ingrid Libman, Lorenzo Piemonti, David Cuthbertson, Jay M. Sosenko

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure

    The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure gan Robert S. Brumberg, Martin R. Back, Paul A. Armstrong, David Cuthbertson, Murray L. Shames, Brad Johnson, Dennis F. Bandyk

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

    Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 gan Jay M. Sosenko, Jerry P. Palmer, Lisa Rafkin‐Mervis, Jeffrey P. Krischer, David Cuthbertson, Della Matheson, Jay S. Skyler

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes

    Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes gan Ping Xu, Yougui Wu, Yiliang Zhu, Getachew Dagne, Giffe T. Johnson, David Cuthbertson, Jeffrey P. Krischer, Jay M. Sosenko, Jay S. Skyler

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

    Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants gan Jay M. Sosenko, Jerry P. Palmer, Lisa Rafkin, Jeffrey P. Krischer, David Cuthbertson, Carla J. Greenbaum, George S. Eisenbarth, Jay S. Skyler

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial–Type 1

    Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial–Type 1 gan Jay M. Sosenko, Jerry P. Palmer, Lisa Rafkin‐Mervis, Jeffrey P. Krischer, David Cuthbertson, Jeffery Mahon, Carla J. Greenbaum, Catherine C. Cowie, Jay S. Skyler

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

    Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 gan Tihamer Orban, Jay M. Sosenko, David Cuthbertson, Jeffrey P. Krischer, Jay S. Skyler, Richard A. Jackson, Liping Yu, Jerry P. Palmer, Desmond Schatz, George S. Eisenbarth

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial–Type 1

    A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial–Type 1 gan Jay M. Sosenko, Jeffrey P. Krischer, Jerry P. Palmer, Jeffrey L. Mahon, Catherine C. Cowie, Carla J. Greenbaum, David Cuthbertson, John M. Lachin, Jay S. Skyler

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)

    An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's) gan Carol A. Langford, Paul A. Monach, Ulrich Specks, Philip Seo, David Cuthbertson, Carol A. McAlear, Steven R. Ytterberg, Gary S. Hoffman, Jeffrey P. Krischer, Peter A. Merkel

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes

    Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes gan Mikkael A. Sekeres, Alan F. List, David Cuthbertson, Ronald Paquette, Rebecca Ganetsky, D Latham, Katarina Paulic, Manuel Afable, Hussain I. Saba, Thomas P. Loughran, Jaroslaw P. Maciejewski

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes

    Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes gan Jay S. Skyler, Jeffrey P. Krischer, Joseph I. Wolfsdorf, Catherine C. Cowie, Jerry P. Palmer, Carla J. Greenbaum, David Cuthbertson, Lisa Rafkin‐Mervis, H. Peter Chase, Ellen W. Leschek

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study

    Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study gan Jay M. Sosenko, Jay S. Skyler, Jeffrey L. Mahon, Jeffrey P. Krischer, Craig A. Beam, David Boulware, Carla J. Greenbaum, Lisa Rafkin, Catherine C. Cowie, David Cuthbertson, Jerry P. Palmer

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

    Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis gan Peter A. Merkel, David Cuthbertson, Bernhard Hellmich, Gary S. Hoffman, David Jayne, Cees G. M. Kallenberg, Jeffrey P. Krischer, Raashid Luqmani, Alfred Mahr, Eric L. Matteson, Ulrich Specks, John H. Stone

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

    Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes gan Jay M. Sosenko, Jay S. Skyler, Jeffrey L. Mahon, Jeffrey P. Krischer, Carla J. Greenbaum, Lisa Rafkin, Craig A. Beam, David Boulware, Della Matheson, David Cuthbertson, Kevan C. Herold, George S. Eisenbarth, Jerry P. Palmer

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis

    New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis gan Peter C. Grayson, David Cuthbertson, Simon Carette, Gary S. Hoffman, Nader Khalidi, Curry L. Koening, Carol A. Langford, Kathleen Maksimowicz‐McKinnon, Paul A. Monach, Philip Seo, Ulrich Specks, Steven R. Ytterberg, Peter A. Merkel

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis

    Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis gan Peter C. Grayson, Gunnar Tómasson, David Cuthbertson, Simon Carette, Gary S. Hoffman, Nader Khalidi, Carol A. Langford, Carol A. McAlear, Paul A. Monach, Philip Seo, Kenneth J. Warrington, Steven R. Ytterberg, Peter A. Merkel

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: